SEC Form D · filed October 26, 2020
Solid Biosciences Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (41)
Martha Osier · Saint-Pierre, O4ExecWayne M. Rehberger · BALTIMORE, MDDirectorFlorent De Boissieu · Saint-Pierre, O4DirectorRajeev Shah · San Francisco, CADirectorAdam Stone · Mamaroneck, NYDirectorLuke Walker · WILMINGTON, DEDirectorSamuel B. Cates · Boston, MAExec · DirectorMartin A. Freed · Cambridge, MADirectorLisa Audet · Greenwich, CTExecStephane Bacquaert · Saint-Pierre, O4DirectorTom Werthan · BALTIMORE, MDDirectorLorenzo Delzoppo · WILMINGTON, DEDirectorAlexis Caude · Saint-Pierre, O4ExecPavel Livshiz · New York, NYDirectorRajeev A. Shah · Cambridge, MADirectorNnennia Ejebe · Saint-Pierre, O4ExecJennifer Ziolkowski · Cambridge, MAExecMartin Freed · Cambridge, MADirectorCarl Morris · Cambridge, MAExecSukumar Nagendran · Cambridge, MADirectorCharles Boatin · Saint-Pierre, O4DirectorJared Kehe · Allston, MAExecLynette Herscha · Cambridge, MAExecChris M. Rosenthal · BALTIMORE, MDDirectorKeith M. Jackson · BALTIMORE, MDDirectorAdam Mullinax · Boston, MAExecAntoine Delaporte · Saint-Pierre, O4ExecDavid Shainok · New York, NYDirectorJoel Schneider · Cambridge, MAExecRobert Huffines · Cambridge, MADirectorRon Efroni Rotman · New York, NYDirectorMatthew Arnold · Houston, TXDirectorJeffrey B. Beir · Boston, MAExecChristophe Scalbert · Saint-Pierre, O4Exec · DirectorIan Smith · New York, NYDirectorIan Smith · Windermere, FLDirectorIlan Ganot · Cambridge, MAExec · DirectorAdam Koppel · Cambridge, MADirectorMark Goode · WILMINGTON, DEDirectorLynne Sullivan · Boston, MADirectorAndrew Gavin · BALTIMORE, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗